CDNA - Caredx Inc

18.25
-0.230   -1.260%

Share volume: 1,025,788
Last Updated: 04-28-2025
Healthcare/Services – Health: 0.18%

PREVIOUS CLOSE
CHG
CHG%
$18.48
-0.23
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
23%
Profitability 8%
Dept financing 9%
Liquidity 67%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.30%
1 Month
2.82%
3 Months
-19.10%
6 Months
-19.25%
1 Year
122.56%
2 Year
119.88%
Key data
Stock price
$18.25
P/E Ratio 
21.85
DAY RANGE
$17.70 - $18.71
EPS 
$1.00
52 WEEK RANGE
$8.43 - $34.84
52 WEEK CHANGE
$135.18
MARKET CAP 
1.148 B
YIELD 
N/A
SHARES OUTSTANDING 
52.740 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.16
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$587,615
AVERAGE 30 VOLUME 
$690,100
Company detail
CEO: Reginald Seeto
Region: US
Website: caredx.com
Employees: 740
IPO year: 2014
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients. AlloSeq Tx, a high-resolution HLA typing solution, is used to type human leukocyte antigen (HLA) alleles.

Recent news
loading